Bluejay Diagnostics, Inc. — Form 8-K
Filed October 13, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
Bluejay Diagnostics achieved a contractual milestone with Toray Industries by establishing a manufacturing site for Symphony cartridges at SanyoSeiko Co., Ltd. in Japan ahead of the October 23, 2026 deadline. The company also established a complementary U.S. manufacturing relationship with ALURIS Sciences to create a diversified, resilient supply chain. No financial terms, share counts, or dollar amounts were disclosed.
Why this rating
Manufacturing readiness is operationally important for a pre-revenue diagnostic company but avoids regulatory/bankruptcy risk. Modest milestone relative to $2.6M market cap; no material financing or partnership value disclosed.
See more from October 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.